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Summary 
After replication  at sites of initial inoculation,  herpes  simplex virus type  1 and  2  (HSV-1  and 
HSV-2) establish lifelong latent infections of the sensory and autonomic neurons of the ganglia 
serving those sites.  Periodically,  the virus reactivates from these neurons,  and travels centripe- 
tally along the neuronal  axon to cause recurrent  epithelial infection.  The major clinically ob- 
served  difference  between infectious  with  herpes  simplex virus type  1 and  type 2  is the  ana- 
tomic  site  specificity  of recurrence.  HSV-1  reactivates  most  efficiently  and  frequently  from 
trigeminal ganglia, causing recurrent ocular and oral-facial lesions, while HSV-2 reactivates pri- 
marily from  sacral  ganglia  causing  recurrent  genital  lesions.  An  intertypic  recombinant  virus 
was constructed and evaluated in animal models of recurrent ocular and genital herpes.  Substi- 
tution  of a  2.8-kbp  region  from  the  HSV-1  latency-associated  transcript  (LAT)  for  native 
HSV-2 sequences caused HSV-2 to reactivate with an HSV-1 phenotype in both animal mod- 
els.  The  HSV-2 phenotype  was  restored  by replacing  the  mutated  sequences  with  wild-type 
HSV-2 LAT-region sequences.  These sequences  or their products  must act specifically in the 
cellular  environments  of trigeminal  and  sacral  neurons  to  promote  the  reactivation  patterns 
characteristic of each virus. 
p primary  or  initial  infections  with  herpes  simplex  virus 
type  1 and 2  (HSV-1  and HSV-2) ~ are clinically indis- 
tinguishable.  While  social habits and other factors contrib- 
ute  to varying sites of initial infections,  the predilection  of 
virus  to  reactivate  from  specific  ganglionic  sites  maintains 
the well-known  associations of HSV-2 with genital herpes 
and of HSV-1 with ocular and oral-facial herpes (1, 2). The 
HSV  latency-associated  transcripts  (LATs)  are  a  family  of 
transcripts  specified  by  the  genomic  long  repeat  regions. 
The more abundant nuclear LAT introns (2.2 kbp in HSV-2 
[3-5],  2.0  kbp and  1.5  kbp in HSV-1  [6-9])  are processed 
via a splicing mechanism from less stable ~8.5-kbp primary 
LAT  transcripts  (10).  The  LATs  of HSV-1  and  HSV-2 
(11-13)  are required  for efficient reactivation  from latency 
in vivo, but have not been shown to influence  acute repli- 
cation of virus or establishment  of latency  (14-19)  in most 
1Abbreviations used in this paper: HSV-1 and HSV-2, herpes simplex virus 
type  1 and  2;  LAT,  latency-associated transcript; PI  postinoculation; 
PRK, primary rabbit kidney. 
animal models, although  there is some evidence suggesting 
an effect on establishment  of latency in a  mouse model of 
infection with HSV-1  (20).  The sequences  of the LAT re- 
gions  differ  significantly  between  HSV-1  and  HSV-2  (4, 
21,  22),  leading  to  the  hypothesis  that  differences  in  the 
LATs  could  be  responsible  for site-specificity  of virus  re- 
currence.  To test this hypothesis, we introduced an alteration 
into HSV-2 strain 333 that substituted the LAT region from 
HSV-1  strain  17syn+  for native  HSV-2  LAT  sequences, 
and  constructed  a  rescuant  of this  mutant.  We  then  tested 
the ability of parent,  mutant,  and rescuant viruses to repli- 
cate and reactivate in a rabbit eye model of recurrent ocular 
herpes, and a guinea pig model of recurrent genital herpes. 
Materials and Methods 
Cells and Viruses.  Vero  cells  were  obtained  from  American 
Type Culture  Collection  (ATCC,  1Kockville,  MD),  and  main- 
tained in  1:1 minimum essential  medium~medium  199,  (Quality 
Biologicals,  Gaithersburg,  MD)  with  10% heat-inactivated  fetal 
bovine serum  (Quality Biologicals,  Gaithersburg,  MD)  and  1% 
GASP (a mixture oft-glutamine, aureomycin, streptomycin, and 
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plex virus type  2,  strain  333,  was  obtained from Gary Hayward 
(Johns Hopkins University, Baltimore, MD). Herpes simplex vi- 
rus  type  1,  strain  17syn+,  was  obtained  from  Dr.  John  Hay 
(SUNY-Buffalo, Buffalo NY). Virus stocks were grown in Vero 
cells, and plaque titered in duplicate before inoculation of animals. 
Mutant  Virus Construction.  Sequences  homologous  to  the 
Xhol  site  in the  HSV-2  LAT region were  introduced  via site- 
directed  mutagenesis  into  an  Avr2-Alul  clone  of the  HSV-1 
LAT region sequences.  This mutation was verified by DNA se- 
quencing.  For  the  nqutant  virus,  the  2820  bp  HSV-1  strain 
17syn+  Notl-Xhol  fragment  was  inserted  between  Not1  and 
Xhol  sites  of a  clone  spanning  the  HSV-2  strain  333  Sphl- 
BamH1  fragment shown in Fig.  l. This DNA was used to con- 
struct  the  mutant  virus  by  homologous  recombination  with 
HSV-2 strain 333  DNA as described (18).  After identification of 
mutant  virus,  plaque  purification was  performed until  Southern 
hybridization  identified no  evidence of contamination  with  the 
parent.  At  this  point,  two  additional  plaque  purifications  were 
performed to yield a stock of HSV-2 333/LAT1. This procedure 
was  repeated,  using  wild-type  Sphl-BamHl  DNA  and  333/ 
LAT1  DNA to produce the rescuant,  HSV-2 333/LAT1R..  Ad- 
ditional  Southern  hybridizations  using  32p-radiolabeled  probes 
were performed to validate the correctness of each virus stock. 
Animal Studies.  All  animal  experiments  were  performed  in 
AAALAC-certified facilities. New Zealand white rabbits weigh- 
ing 2,000-2,500  g  were infected with each virus in three  inde- 
pendent experiments. Scarified (in one experiment) or unscarified 
(in two experiments)  rabbit eyes were inoculated by gentle rub- 
bing of a 25-1*1 suspension containing I05 PFU ofHSV-I  17syn+, 
HSV-2 333, HSV-2 333/LATI, or HSV-2 333/LAT1R. In each 
experiment,  except  for  virus  inoculated,  animals  infected  with 
each virus were treated identically. After inoculation, all manipu- 
lations  and  observations  were  performed  by  investigators  who 
were  masked  as  to  inoculating  virus.  5-6  wk  after inoculation, 
transcorneal  iontophoresis  of 0.01%  epinephrine  (0.8  mA for  8 
rain, once a day for three consecutive days)  was used to attempt 
induction of ocular viral shedding from unscarred  eyes. No eyes 
shed  vires  for  any  of the  3  d  before  iontophoresis.  Eye  swabs 
were  taken  daily  for  7-9  d  after  the  first  iontophoresis.  Swabs 
were cultivated on primary rabbit kidney (PRK) cells, and deter- 
mined to be positive if cytopathic effect consistent with HSV in- 
fection was  observed.  Two independent  experiments were per- 
formed in guinea pigs. Female Hartley guinea pigs (Charles River 
Breeding  Laboratories,  Wilmington  MA)  weighing  400-525  t,, 
were inoculated with 105.7 PFU of each virus on day 0 by rupture 
of the vaginal closure membrane with a moistened calcium algi- 
hate tipped swab  and instillation of 0.l  cc virus.  Lesion severity 
was  scored  daily  (on  a  scale  from  0-4)  until  resolution  of the 
acute infection. Disease severity was calculated as the area under 
the lesion score-day curve, for the duration of the acute infection. 
These  same guinea pigs were observed daily for recurrence  fre- 
quency from days 15-63 after inoculation. All observations of the 
guinea pigs were performed by investigators masked as to inocu- 
lating virus.  Guinea  pigs that  were  not  evaluable for the  entire 
observation period (either primary or recurrence phase)  were ex- 
cluded from analysis. 
Cocultivation and Quantitative Polymerase Chain Reaction.  Trigem- 
inal ganglia were  removed from rabbits  after completion  of the 
epinephrine  iontophoresis experiments,  removed from the outer 
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Figure  1.  HSV-2  and  HSV-1  LAT re- 
gions.  HSV-2  sequences  are  shown  above 
the dashed line, HSV-1 sequences are below 
the dashed line.  Transcripts  and  restriction 
endonuclease  cleavage  sites in  this  region 
are  shown  for  each  virus.  Boxes  within 
transcripts represent introns. The 2.8 kbp of 
HSV-I LAT sequence that was inserted into 
the Sphl-Banflql clone including the HSV-2 
LAT region is  shaded. The  Sphl-BamH1 
fragment  was  also used  as  a  probe  in  the 
Southern  hybridizations,  along  with  the 
HSV-1  Sphl-Sphl  and  the  HSV-2 Notl- 
Sail  fragnnents (hatchmarked boxes). LA T, la- 
tency-associated  transcript;  ICPO, infected 
cell  protein  0,  an  immediate-early  viral 
transactivator; ICP4, infected cell protein  4, 
an  immediate-early  viral  transactivator; 
ICP34.5,  infected  cell protein  34.5,  impli- 
cated  in  prevention of neuronal  apoptosis; 
ORF-P,  open  reading  frame  P  transcript, 
function  unknown;  TR  L,  terminal  repeat, 
long; U  L, unique,  long; IR> internal repeat, 
long; /R.s, internal repeat, short; U  s, unique, 
short; TRs, terminal repeat, short. 
660  Control of HSV Site-specific Reactivation Patterns Figure  2.  Southern hybridization of DNA extracted from HSV~2 333 
(lanes  1,  4, and  7),  HSV-2 333/LAT1 (lanes 2, 5, and 8), and HSV-2 
333/LAT1R  (lanes 3, 6, and 9). DNA was cleaved with Sphl, and sub- 
jected to Southern hybridization with  an HSV-2 Sphl-BamHl  probe 
(lanes I-3), an HSV-2 sequence-specific Notl-Sall probe (lanes 4-6), or 
an HSV-1 sequence-specific Sphl-Sphl  probe (lanes 7-9). Marker sizes 
(in kbp) are shown to the left of the gel. 
sheath,  separated  into two  or three  pieces,  and placed  in tissue 
culture  with  PRK  cells. Cultures  were  observed daily  for evi- 
dence of cytopathic effect,  and reported as positive  on the  first 
day that HSV cytopathic effect was evident. 
Ganglionic  DNA  was  extracted  from  trigeminal  ganglia  of 
three rabbits latently  infected with each virus and from three un- 
infected rabbits.  PCR controls consisted  of 100 ng of DNA ex- 
tracted from an uninfected rabbit  trigeminal  ganglion spiked with 
101 to 106 copies of HSV-2 DNA in 10-fold increments. In each 
reaction, 100 ng (quantified  spectrophotometrically) of DNA was 
subjected to coamplification with two primer pairs by polymerase 
chain reaction (94~  X 1 min, 55~  X 1 min, 72~  X 2 min) for 
30 cycles. The primers were GAACCACGGGCTGATGTTTG 
and  CAATGCGTAGACGGAGAAAAAGAG (which  are  spe- 
cific for a 181-bp product in the HSV-2 glycoprotein C region), 
and CCATTCATTGACCTCCACTACATGG and TCGCTC- 
CTGGAAGATGGTGATG  (which  are  specific  for  a  134-bp 
product  in  rabbit  glyceraldehyde-3-phosphate  dehydrogenase). 
The products were alkaline  denatured and subjected to slot blot- 
ting on Nytran membranes  (Schleicher  & Schuell,  Keene,  NH) 
using a 32p-radiolabeled  probes derived either by end-labeling an 
oligonucleotide internal to the rabbit G3PDH product (TGTTC- 
CAGTATGATTCCACC)  or  by  random  priming  of a  l-kbp 
gel-pure  Bgl2-BstE2  fragment from within  HSV-2 gC.  Signals 
were  quantified  using a  Phosphorlmager  (Molecular Dynamics, 
Inc., Sunnyvale, CA). For each sample,  the ratio of the HSV-2/ 
G3PDH  signals was  calculated  and  compared  with  scores  ob- 
tained  using  the  spiked  controls.  The  approximate  number  of 
copies  of HSV DNA in the three ganglia  latently  infected with 
each  virus  was  calculated  by  linear  extrapolation  between  the 
spiked  control  scores  directly  above  and  below  those  for  each 
sample.  Controls using DNA from the  three  uninfected rabbits 
and using no template (oligonucleotide primers only) gave rise to 
no signal attributable  to HSV. 
Results 
Mutant  Virus Construction and Evaluation.  To test our hy- 
pothesis, we introduced an alteration into HSV-2 strain 333 
which  substituted  the  LAT  region  from  HSV-1  strain 
17syn+  for native HSV-2 LAT sequences,  and designated 
this  virus  HSV-2  333/LAT1  (Fig.  1).  The  substituted  se- 
quences start upstream of the LAT promoter and include the 
LAT promoter,  primary LAT 5'  end sequences,  and most 
LAT intron sequences  (excluding only 160 bases from the 
3' end of the LAT intron). A rescuant HSV-2 333/LAT1R 
was constructed by replacing the substituted HSV-1 sequences 
in HSV-2 333/LAT1 with parent HSV-2 sequences. 
The construction of the mutant and rescuant viruses rel- 
ative  to  the  sequences  of the  parent  virus  was  verified by 
Southern  hybridization.  Purified  DNA  extracted  from 
HSV-2 333,  HSV-2 333/LAT1,  and HSV-2 333/LAT1R 
was cleaved with the restriction endonuclease Sphl  (Fig. 2) 
and probed with  radiolabeled  DNA fragments  specific for 
the  HSV-2  and  HSV-I  LAT  regions.  In  DNA  extracted 
from  wild-type  and  rescuant  virus,  a  probe  spanning  the 
HSV-2 Sphl-BamH1  region  (Fig. 2, lanes  1-3)  detected  a 
predicted 4,083-bp fragment within  the long repeat,  and a 
doublet  of 3,073  and 2,829 bp representing fragments that 
span Sphl  sites  present within the unique-long segment on 
either side of the HSV-2 genomic repeats and the first Spht 
site  within  the repeats.  Smaller  (<200 bp)  Sphl  fragments 
are  not visualized  on  this  gel.  Changes  in  the  location  of 
the first Sphl  site within the repeats led to detection of the 
predicted  fragments  of 4,169  bp  for the  larger  band,  and 
2,236 and 1,992 bp for the doublet in the mutant virus. An 
internal  HSV-1  derived 786-bp  Sphl  fragment in the mu- 
tant  lacks  homology  with  the  HSV-2  sequences  in  the 
probe,  and is  not detected.  A  probe  spanning  the  HSV-2 
Notl-Sall  region  (lanes  4-6), which is specific for HSV-2 
sequences,  detected  the  appropriate  doublets  in  wild-type 
and rescuant virus, and showed no homology with mutant 
virus  sequences.  A  probe  spanning  the  HSV-1  786  bp 
Sphl-Sphl  region  (lanes  7-9)  detected  only  the  786-bp 
Sphl  fragment in the mutant virus, and showed no homol- 
ogy  with  wild-type  or  rescuant  sequences.  Additional 
Southern hybridizations with BamH1, EcoRV, Not1, Sall, 
and Xhol  digests of virus DNA also yielded the predicted 
results  when  hybridized  with  these  probes  (data  not 
shown). Each virus displayed similar one-step growth char- 
acteristics  in  Vero  cells,  indicating  that  the  LAT  substitu- 
tion  did  not  influence  the  ability  of the  mutant  virus  to 
grow in tissue culture  (data not shown). 
Assessment  of L/IT  Subsitution  In  Vivo  in  Rabbit  Eyes. 
The rabbit ocular model of HSV-1  infection mimics natu- 
ral  human  infection  with  HSV-1.  The  virus  causes  acute 
ocular  infections,  establishes  latency  in  trigeminal  ganglia, 
and  can  be  induced  to  reactivate  by  appropriate  stimuli 
(14). Also similar to human infections, HSV-2 does not re- 
activate well in vivo from rabbit trigeminal ganglia. 
After corneal inoculation with HSV-2 333, HSV-2 333/ 
LAT1, HSV-2 333/LAT1R, or HSV-1  17syn+, all rabbits 
exhibited  comparable acute epithelial  HSV keratitis  during 
661  Yoshikawa  et al. Table  1.  Induced  Reactivation (via Ocular lontophoresis of 
Epinephrine) qfl HS V Mutants from Latently  Infected Rabbits 
Table 2.  Acute and Spontaneous Recurrent Infections of HSV 
Mutants  in Guinea Pigs 
No. of  Positive  eyes/  Positive swabs/ 
Virus  rabbits*  total eyes*  total swabs~ 
HSV-1  17 syn+  7  10/14 (71%)  30/101  (30%) 
HSV-2 333  6  1/10 (10%)  1/80  (1%) 
HSV-2/LAT1  6  5/9  (56%)  14/68  (21%) 
HSV-2/LAT1R  10  2/19 (t 1%)  3/152 (2%) 
*Cumulative data from three independent experiments. 
*P <0.05 by Fisher exact test for all pairwise comparisons except be- 
tween 17syn+ vs. HSV-2 333/LAT1 and HSV-2 333 vs. HSV-2 333/ 
LAT  1  IL. 
5P <0.001  by Chi Square analysis for all pairwise comparisons except 
between  17syn+  vs.  HSV-2 333/LAT1  and HSV-2 333 vs.  HSV-2 
333/LATI t(. 
postinoculation  (PI)  days 3-6.  All  tested  eyes  had  cleared 
and showed no epithelial  defect by 21  d  after inoculation. 
We  enumerated  ocular  recurrences  in  three  independent 
experiments  of latently infected rabbits  subjected to ocular 
iontophoresis of epinephrine  (summarized in Table 1). The 
procedure efficiently induced reactivation from rabbit eyes 
inoculated  with  HSV-1  strain  17  syn+;  71%  of eyes and 
30%  of swabs  yielded  virus  after  iontophoresis.  As  ex- 
pected, wild-type HSV-2 333 did not reactivate well from 
the  latently  infected  rabbits  (10%  of eyes,  1%  of swabs). 
The  rescuant  333/LATIR  behaved  similarly to wild-type 
HSV-2  333.  However,  the  mutant  333/LAT1  reactivated 
almost  as  efficiently  as  HSV-1  did  (56%  of eyes,  21%  of 
swabs).  All positive swabs were verified to contain the in- 
oculated virus by Southern hybridization (data not shown). 
Thus,  the  ability  to  reactivate  efficiently  from  rabbit 
trigeminal  ganglia  was  conferred  on  HSV-2  by DNA  se- 
quences from the HSV-1 LAT region. 
In Northern  hybridizations  of KNA  extracted  from la- 
tently infected rabbit trigeminal ganglia and from Vero cells 
productively infected  with  each  virus,  HSV-2  333/LAT1 
appropriately transcribed LATs indistinguishable fi-om those 
of HSV-I  17syn+,  and  HSV-2  333  transcribed  LATs in- 
distinguishable from those of 333/LAT1R (data not shown). 
There  was  also  no  difference  in  the  quantity  of LAT ex- 
pressed  during  latent  infection  by  the  wild-type,  nmtant, 
and resonant viruses. 
Assessment of LA T  Substitution  In  Vivo in  Guinea Pig Gen- 
italia.  We next examined the  effect of the LAT substitu- 
tion  mutation  on viral  infection in  a guinea pig model  of 
genital herpes.  As is the case in humans,  HSV causes acute 
infections  of guinea pigs,  establishes  latency in  sacral gan- 
glia,  and  reactivates  spontaneously  to  cause  recurrent  le- 
sions (23, 24).  In the guinea pig genital model, HSV-2 also 
recurs significantly more frequently than does HSV-1. Two 
independent  experiments  were  perfomaed  in  guinea  pigs, 
each yielding sinfilar results.  The severity of the primary in- 
fections as assessed  by the area under the lesion-score curve 
Virus* 
Primary (dl-14) genital 
skin disease severity 
mean +  SE 
(no. of animals) 
Days with 
recurrent genital 
skin lesions (dl 5-63) 
mean +  SE 
(no. of animals) 
HSV-1  17syn+  4.3  ~  0.8 (10)  0.9 +  0.6 (10) 
HSV-2 333  5.3 --+ 1.t  (9)  4.t  +  1.6 (9) 
HSV-2/LATt  5.2  +  0.8 (13)  1.5 +  0.5 (1 l) 
HSV-2/LAT1-R  4.8 --- 0.5 (14)  5.9  +  1.0 (14) 
*Cumulative data from two independent experiments. 
was similar for guinea pigs infected with HSV-2 333, HSV-2 
333/LAT1, HSV-2 333/LAT1R, or HSV-1  17syn+, indi- 
cating no differences in the abilities  of these viruses to rep- 
licate or cause acute disease in guinea pigs (Table 2). 
After  recovery from  acute  infection,  guinea  pigs  were 
examined for recurrent lesions daily from days  15-63 post 
inoculation. Infections with HSV-2 strain 333 and HSV-2/ 
LATltL resulted in frequent recurrences (mean 4.1, SE 1.6, 
and  mean  5.9,  SE  1.0,  respectively),  while  the  mutant 
HSV-2  333/LAT1  recurred  with  a  frequency comparable 
to  that  of HSV-I  strain  17syn+  (mean  0.9,  SE  1.6,  and 
mean  1.5,  SE 0.5,  respectively).  Thus,  higher reactivation 
frequencies  from guinea pig sacral ganglia were  associated 
with the presence of sequences from the HSV-2 LAT region. 
Assessment of the LA T  Region Substitutions on EstablMlment 
of Latency.  In previous experiments,  deletions in the LAT 
region  did  not influence  establishment  or maintenance  of 
viral latency in rabbits (14)  and guinea pigs (18), although it 
did in mice (20). Previous studies in which latent virus was 
recovered in tissue culture from explanted guinea pig sacral 
ganglia also showed no difference between  recovery of la- 
Table  3.  Virus  recovery  from latentl  F infected rabbit 
trigeminal gauglia b), cocultivation and detection of viral DNA b), 
quantitative PCR 
Virus 
PCP, 
Detection by Cocultivation  Mean HSV 
genomes 
No. positive/Average days  per 100 ng 
total ganglia  to positive  Range  TG 1)NA* 
HSV-1 17syn+  1/1  11 
HSV-2 333  4/4  14 
HSV-2/LAT1  2/2  21 
HSV-2/LAT1-R  5/5  16 
d 
11  Not done 
10-24  1.8 ￿  10  ~ 
17,24  1.2  ￿  10 2 
12-17  1.0  ￿  10  2 
*Mean copy number in three ganglia latently infected with each virus. 
662  Control of HSV Site-specific Reactivation Patterns tent HSV-1  or HSV-2.  In our study,  virus was recovered 
from all  rabbit ganglia subjected  to  explant  cocultivation, 
and with approximately the same kinetics (Table 3). South- 
ern hybridizations confirmed the appropriate restriction en- 
donuclease  digestion patterns  for each virus recovered by 
cocultivation  (data  not  shown).  Similar  conclusions  were 
reached  regarding latent  viral DNA  content  in  the  PCR 
experiments. Although there was variability in the quantity 
of HSV  DNA  detected  in  ganglia,  the  quantity  of viral 
DNA in rabbit ganglia latently infected with HSV-2 333/ 
LAT1 was comparable to that in animals infected with the 
wild-type virus. This indicates that potential differences in 
establishment or maintenance of latency could not explain 
the differences in reactivation frequency. 
Discussion 
The  present  study  demonstrates  that  site-specific  virus 
reactivation depends  upon  LAT-region sequences.  In the 
context of either HSV-1  or HSV-2, the  HSV-1  LAT re- 
gion is  both necessary and  sufficient for the  HSV-1  site- 
specific reactivation phenotype from sacral and trigeminal 
ganglia.  The HSV-2 LAT region is necessary for the HSV-2 
phenotype of efficient reactivation from sacral ganglia,  al- 
though  a potential requirement for additional,  as-yet uni- 
dentified  HSV-2-specific viral factors is  not  strictly  ruled 
out  by  these  experiments.  The  precise  mechanism  by 
which the LAT region expresses this phenotype is unclear. 
It is  conceivable,  although  unlikely,  that  the  site-specific 
reactivation  phenotype  could  be  attributable  to  the  small 
exchange of 3 r ICP0 sequences between HSV-1 and HSV-2 
in the mutant virus.  However, the mutation did not shift 
the  ICP0 reading frame, and there  are  only minor differ- 
ences  in  ICP0  3'  amino  acid  sequences  between  HSV-1 
and  HSV-2.  We  were  unable  to  identify  any phenotypic 
differences between the viruses which would be expected 
to  be  associated with  alterations  in  ICP0  function  (ICP0 
appeared  normal  on  Northern  hybridizations  of produc- 
tively  infected  Vero  cells  [data  not  shown];  one-step 
growth, acute infections, and recovery by cocnltivation of 
the viruses were normal). 
The HSV-1 and HSV-2 LAT promoters have very simi- 
lar sequences, and in this experiment did not differ substan- 
tially in their ability to  direct latent transcription  of LAT. 
Moreover, previous studies have indicated that differences 
in  the  quantities  of LATs transcribed  by HSV  during  la- 
tency are not associated with differences in recurrence phe- 
notypes (25,  26).  Thus, LAT promoter sequences are also 
unlikely to be directly responsible for site-specific reactiva- 
tion, although we cannot exclude differences in expression 
during  reactivation which  are not evident during latency. 
Because the reactivation phenotype was independent of the 
ability to transcribe latent LAT RNA, the LAT-associated 
phenotype  is  probably  not  attributable  to  an  antisense 
mechanism (e.g., with ICP0). The LAT phenotype also ap- 
pears  unlikely  to  be  attributable  to  LAT  sequences  tran- 
scribed under the control of the LAT promoter, but down- 
stream of  the substituted Notl-Xhol fragment. Theoretically, 
HSV reactivation could be controlled by another as yet un- 
identified transcript under the control of the LAT promoter. 
There  are  no  well-conserved  potential  open  reading 
frames between HSV-1  and HSV-2 in the LAT sequences 
we substituted.  Experiments in which viruses with  muta- 
tions  disrupting  potential  open reading frames within  the 
HSV-1 LAT intron were evaluated in rabbits and mice, in- 
dicated  that  these  theoretical  open reading frames do  not 
play a role in virus reactivation  (27,  28).  Thus,  it appears 
unlikely that a protein encoded by LAT is responsible for 
its effect on reactivation. 
These results imply that the LAT region confers the phe- 
notype  of efficient site-specific reactivation,  which  is  the 
major  clinically  relevant  phenotypic  difference  between 
HSV-1  and HSV-2. Site-specificity of reactivation appears 
to be most dependent on differences in ability to reactivate 
from the  ganglion,  rather than differences in access  to the 
ganglion.  Consistent  with  previous  reports  of LAT  mu- 
tants, we identified no effect of our mutation on the ability 
of the virus to replicate acutely or to establish or maintain 
latency in either animal model. Thus, products of this ge- 
nomic region  (possibly the  LAT RNAs  themselves)  must 
act in a specific manner within the cellular milieu of either 
trigeminal  or  sacral  ganglia.  This  experiment  definitively 
assigns to the LAT region an active and critical role in virus 
reactivation  from latency.  Additional  studies  of chimeric 
viruses, for example, in which HSV-2 LAT sequences are 
substituted  for  wild-type  HSV-1  sequences  or  in  which 
smaller regions are substituted between  HSV-1  and HSV-2 
will yield further insight into the role of the LAT in site- 
specific reactivation. Further study of interactions between 
cellular  constituents  and  the  LAT  DNA  and  RNA  se- 
quences  should  yield  a  fundamental  understanding  of the 
mechanisms both of anatomic site-specific reactivation, and 
of herpes simplex virus reactivation in general. 
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